Calcified Tissue International

, Volume 90, Issue 5, pp 420–428 | Cite as

Two Molecular Weight Species of Thrombospondin-2 Are Present in Bone and Differentially Modulated in Fractured and Nonfractured Tibiae in a Murine Model of Bone Healing

  • Andrea I. Alford
  • Anita B. Reddy
  • Steven A. Goldstein
  • Prithvi Murthy
  • Riyad Tayim
  • Gorav Sharma
Original Research


We report two immuoreactive species of thrombospondin-2 (TSP2), sized approximately 200 and 125 kDa, in the long bones of growing, but not skeletally mature, mice. In vitro osteoblasts secrete a 200-kDa species into the culture medium as early as day 3, and it appears in the cell-matrix layer by day 7. A 125-kDa species appears in the cell-matrix layer in parallel with mineralization; it is not detected in cell-conditioned medium. Unilateral tibial fracture induced a time-dependent upregulation of the 200-kDa species at the site of trauma. By contrast, relative levels of the 125-kDa species at the fracture site were lower than in bones from naive control animals. In the contralateral untouched control tibia, the 200-kDa species was rapidly and substantially reduced compared to bone harvested from naive control mice. Levels of the 125-kDa species in the untouched tibia declined gradually with time postfracture. TSP2 gene expression in uninjured control bone decreased modestly by 21 days postfracture. On the day of fracture, the osteoblast differentiation potential of MSCs harvested from uninjured bones decreased compared to those harvested from naive control animals. The presence of two isoforms suggests that TSP2 may undergo posttranscriptional or posttranslational processing in skeletal tissue. Our data also suggest that, in the context of trauma, the two TSP2 isforms are differentially modulated at injured and noninjured skeletal sites in an animal undergoing fracture healing.


Matricellular Thrombospondin-2 Fracture Marrow stromal cell Osteoblast 



We thank Bonnie T. Nolan and Kathy Sweet for expert technical assistance and animal care.


  1. 1.
    Bornstein P, Sage E (2002) Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol 14:608–616PubMedCrossRefGoogle Scholar
  2. 2.
    Bornstein P, Armstrong LC, Hankenson KD, Kyriakides TR, Yang Z (2000) Thrombospondin 2, a matricellular protein with diverse functions. Matrix Biol 19:557–568PubMedCrossRefGoogle Scholar
  3. 3.
    Hankenson KD, Bain SD, Kyriakides TR, Smith EA, Goldstein SA, Bornstein P (2000) Increased marrow-derived osteoprogenitor cells and endosteal bone formation in mice lacking thrombospondin 2. J Bone Miner Res 15:851–862PubMedCrossRefGoogle Scholar
  4. 4.
    Hankenson KD, Bornstein P (2002) The secreted protein thrombospondin 2 is an autocrine inhibitor of marrow stromal cell proliferation. J Bone Miner Res 17:415–425PubMedCrossRefGoogle Scholar
  5. 5.
    Alford AI, Terkhorn SP, Reddy AB, Hankenson KD (2010) Thrombospondin-2 regulates matrix mineralization in MC3T3-E1 pre-osteoblasts. Bone 46:464–471PubMedCrossRefGoogle Scholar
  6. 6.
    Shitaye HS, Terkhorn SP, Combs JA, Hankenson KD (2010) Thrombospondin-2 is an endogenous adipocyte inhibitor. Matrix Biol 29:549–556PubMedCrossRefGoogle Scholar
  7. 7.
    Taylor DK, Meganck JA, Terkhorn S, Rajani R, Naik A, O’Keefe RJ, Goldstein SA, Hankenson KD (2009) Thrombospondin-2 influences the proportion of cartilage and bone during fracture healing. J Bone Miner Res 24:1043–1054PubMedCrossRefGoogle Scholar
  8. 8.
    Volpert OV, Tolsma SS, Pellerin S, Feige JJ, Chen H, Mosher DF, Bouck N (1995) Inhibition of angiogenesis by thrombospondin-2. Biochem Biophys Res Commun 217:326–332PubMedCrossRefGoogle Scholar
  9. 9.
    Kyriakides TR, Zhu YH, Smith LT, Bain SD, Yang Z, Lin MT, Danielson KG, Iozzo RV, LaMarca M, McKinney CE, Ginns EI, Bornstein P (1998) Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J Cell Biol 140:419–430PubMedCrossRefGoogle Scholar
  10. 10.
    Hiltunen A, Vuorio E, Aro HT (1993) A standardized experimental fracture in the mouse tibia. J Orthop Res 11:305–312PubMedCrossRefGoogle Scholar
  11. 11.
    Aubin JE (1999) Osteoprogenitor cell frequency in rat bone marrow stromal populations: role for heterotypic cell–cell interactions in osteoblast differentiation. J Cell Biochem 72:396–410PubMedCrossRefGoogle Scholar
  12. 12.
    Carlson CB, Lawler J, Mosher DF (2008) Structures of thrombospondins. Cell Mol Life Sci 65:672–686PubMedCrossRefGoogle Scholar
  13. 13.
    Lee NV, Sato M, Annis DS, Loo JA, Wu L, Mosher DF, Iruela-Arispe ML (2006) ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2. EMBO J 25:5270–5283PubMedCrossRefGoogle Scholar
  14. 14.
    Lind T, McKie N, Wendel M, Racey SN, Birch MA (2005) The hyalectan degrading ADAMTS-1 enzyme is expressed by osteoblasts and up-regulated at regions of new bone formation. Bone 36:408–417PubMedCrossRefGoogle Scholar
  15. 15.
    Rehn AP, Birch MA, Karlstrom E, Wendel M, Lind T (2007) ADAMTS-1 increases the three-dimensional growth of osteoblasts through type I collagen processing. Bone 41:231–238PubMedCrossRefGoogle Scholar
  16. 16.
    Manduca P, Castagnino A, Lombardini D, Marchisio S, Soldano S, Ulivi V, Zanotti S, Garbi C, Ferrari N, Palmieri D (2009) Role of MT1-MMP in the osteogenic differentiation. Bone 44:251–265PubMedCrossRefGoogle Scholar
  17. 17.
    Geoffroy V, Marty-Morieux C, Le Goupil N, Clement-Lacroix P, Terraz C, Frain M, Roux S, Rossert J, de Vernejoul MC (2004) In vivo inhibition of osteoblastic metalloproteinases leads to increased trabecular bone mass. J Bone Miner Res 19:811–822PubMedCrossRefGoogle Scholar
  18. 18.
    Kyriakides TR, Zhu YH, Yang Z, Bornstein P (1998) The distribution of the matricellular protein thrombospondin 2 in tissues of embryonic and adult mice. J Histochem Cytochem 46:1007–1015PubMedCrossRefGoogle Scholar
  19. 19.
    Bab IA, Einhorn TA (1994) Polypeptide factors regulating osteogenesis and bone marrow repair. J Cell Biochem 55:358–365PubMedCrossRefGoogle Scholar
  20. 20.
    Bab I, Gazit D, Chorev M, Muhlrad A, Shteyer A, Greenberg Z, Namdar M, Kahn A (1992) Histone H4-related osteogenic growth peptide (OGP): a novel circulating stimulator of osteoblastic activity. EMBO J 11:1867–1873PubMedGoogle Scholar
  21. 21.
    Brager MA, Patterson MJ, Connolly JF, Nevo Z (2000) Osteogenic growth peptide normally stimulated by blood loss and marrow ablation has local and systemic effects on fracture healing in rats. J Orthop Res 18:133–139PubMedCrossRefGoogle Scholar
  22. 22.
    Amsel S, Maniatis A, Tavassoli M, Crosby WH (1969) The significance of intramedullary cancellous bone formation in the repair of bone marrow tissue. Anat Rec 164:101–111PubMedCrossRefGoogle Scholar
  23. 23.
    Gazit D, Karmish M, Holzman L, Bab I (1990) Regenerating marrow induces systemic increase in osteo- and chondrogenesis. Endocrinology 126:2607–2613PubMedCrossRefGoogle Scholar
  24. 24.
    Bab I, Gazit D, Massarawa A, Sela J (1985) Removal of tibial marrow induces increased formation of bone and cartilage in rat mandibular condyle. Calcif Tissue Int 37:551–555PubMedCrossRefGoogle Scholar
  25. 25.
    Pignolo RJ, Kassem M (2011) Circulating osteogenic cells: implications for injury, repair, and regeneration. J Bone Miner Res 26:1685–1693PubMedCrossRefGoogle Scholar
  26. 26.
    Kumagai K, Vasanji A, Drazba JA, Butler RS, Muschler GF (2008) Circulating cells with osteogenic potential are physiologically mobilized into the fracture healing site in the parabiotic mice model. J Orthop Res 26:165–175PubMedCrossRefGoogle Scholar
  27. 27.
    Boban I, Barisic-Dujmovic T, Clark SH (2010) Parabiosis model does not show presence of circulating osteoprogenitor cells. Genesis 48:171–182PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Andrea I. Alford
    • 1
  • Anita B. Reddy
    • 1
  • Steven A. Goldstein
    • 1
  • Prithvi Murthy
    • 1
  • Riyad Tayim
    • 1
    • 2
  • Gorav Sharma
    • 1
  1. 1.Department of Orthopaedic SurgeryUniversity of Michigan School of MedicineAnn ArborUSA
  2. 2.Wright State University Boonshoft School of MedicineDaytonUSA

Personalised recommendations